- 83,000$100.3B
1
- 69,400$35.6B
2
- 11,322$5.3B
3
- 50,000$58.1B
4
- 83,100$41.5B
5
- 68,000$59.3B
6
Bristol-Myers Squibb
Manufacturing · New York, United States · 34,300 Employees
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. The company offers chemically-synthesized drug and biologic in various therapeutic areas, such as oncology; cardiovascular; immunoscience; and virology comprising human immunodeficiency virus infection (HIV). Its products include Empliciti, a humanized monoclonal antibody to treat multiple myeloma; Opdivo, a human monoclonal antibody to treat renal cell carcinoma, non-small cell lung cancer, classical Hodgkin lymphoma, gastric cancer, melanoma, metastatic urothelial carcinoma, and squamous cell carcinoma of the head and neck; Erbitux, an IgG1 monoclonal antibody that blocks the epidermal growth factor receptor; Sprycel, a tyrosine kinase inhibitor for the treatment of adults with Philadelphia chromosome-positive chronic myeloid leukemia; and Yervoy, a monoclonal antibody for metastatic melanoma. The companys products also comprise Eliquis, an oral factor Xa inhibitor targeted at stroke prevention in atrial fibrillation; Baraclude to treat chronic hepatitis B virus; Daklinza and Sunvepra to treat hepatitis C virus (HCV); Reyataz and Sustiva to treat HIV; Abilify, an antipsychotic agent for adults with schizophrenia, bipolar mania disorder, and depressive disorder; Beclabuvir, a non-nucleoside NS5B inhibitor for the treatment of HCV; and Orencia to treat rheumatoid arthritis. It has collaboration agreements with Portola Pharmaceuticals, Inc., Apexigen, Inc., and Nordic Bioscience; clinical research collaborations with Array BioPharma, Novartis, Clovis Oncology, Inc., and Daiichi Sankyo; and license agreement with Nitto Denko Corporation to develop and commercialize siRNA molecules targeted at HSP47 in vitamin A. The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York.Read More
View Company Info for Free
Who is Bristol-Myers Squibb
Headquarters
Phone Number
Website
Revenue
Stock Symbol
Industry
Top Competitors of Bristol-Myers Squibb
Compare CEO
How does Giovanni Caforio compare against Competing Companies' CEOs?

Giovanni Caforio
CEO at Bristol-Myers Squibb
CEO effectiveness to drive business results
VS.

CEO effectiveness to drive business results

Joaquin Duato
CEO at Johnson & Johnson

Rob Davis
CEO at Merck

Albert Bourla
CEO at Pfizer

Pascal Soriot
CEO at AstraZeneca
Bristol-Myers Squibb Org Chart
Bristol-Myers Squibb Email Formats
Bristol-Myers Squibb uses at least 5 email formats with first.last (ex. John.Smith@bms.com) being used 86.5% of the time
Bristol-Myers Squibb Email Formats | Percentage | |
---|---|---|
first.last | John.Smith@bms.com | 86.5% |
first + last | JohnSmith@bms.com | |
first_last | John_Smith@bms.com | |
first | John@bms.com | |
last | Smith@bms.com |
Get Verified Emails
Bristol-Myers Squibb Company Metrics
$4B
Total Funding Amount
$4B
Most Recent Funding Amount
3
Number of Funding Rounds
Jul 18, 2022
Celgene
Jul 27, 2017
iZumi Bio
Jan 11, 2014
Turning Point Therapeutics
Oct 06, 2013
Mirati Therapeutics
Oct 12, 2012
MyoKardia
Mar 31, 2012
Receptos
See More Acquisitions & Subsidiaries
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Bristol-Myers Squibb News & Media
Bristol Myers Squibb Presents Primary Efficacy and Safety Analysis of the Phase 3 COMMANDS Trial of Reblozyl for Treatment of Anemia in Erythropoiesis Stimulating Agent-Naïve Patients with Lower-Risk Myelodysplastic Syndromes at ASH 2023
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #ASH--Bristol Myers Squibb Presents Primary Efficacy and Safety Analysis of the Phase 3 COMMANDS Trial of Reblozyl for Treatment of Anemia....12 Biggest Financial Scandals in US History
In this article, we will be taking a look at the 12 biggest financial scandals in U.S. history. To skip our detailed analysis, you can go directly to see the 5 biggest financial scandals in U.S. history. There are few things as serious as a major financial scandal, which don’t just threaten the reputation and […]Bristol Myers Squibb Announces Phase 3 CheckMate -8HW Trial Evaluating Opdivo (nivolumab) Plus Yervoy (ipilimumab) Compared to Chemotherapy in Microsatellite Instability–High or Mismatch Repair Deficient Metastatic Colorectal Cancer Meets Primary...
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #CheckMate--BMS Announces Phase 3 CheckMate -8HW Trial Evaluating Opdivo Plus Yervoy Compared to Chemotherapy in Microsatellite Instability–High or.....Bristol Myers Squibb Announces Additional $3 Billion Share Repurchase Authorization
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb Announces Additional $3 Billion Share Repurchase Authorization
Frequently Asked Questions regarding Bristol-Myers Squibb
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. The company offers chemically-synthesized drug and biologic in various therapeutic areas, such as oncology; cardiovascular; immunoscience; and virology comprising human immunodeficiency virus infection (HIV). Its... Read More